Cargando…
Development of a synoptic MRI report for primary rectal cancer
BACKGROUND: Although magnetic resonance imaging (MRI) is an important imaging modality for pre-operative staging and surgical planning of rectal cancer, to date there has been little investigation on the completeness and overall quality of MRI reports. This is important because optimal patient care...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224933/ https://www.ncbi.nlm.nih.gov/pubmed/19954526 http://dx.doi.org/10.1186/1748-5908-4-79 |
_version_ | 1782217462946725888 |
---|---|
author | Spiegle, Gillian Leon-Carlyle, Marisa Schmocker, Selina Fruitman, Mark Milot, Laurent Gagliardi, Anna R Smith, Andy J McLeod, Robin S Kennedy, Erin D |
author_facet | Spiegle, Gillian Leon-Carlyle, Marisa Schmocker, Selina Fruitman, Mark Milot, Laurent Gagliardi, Anna R Smith, Andy J McLeod, Robin S Kennedy, Erin D |
author_sort | Spiegle, Gillian |
collection | PubMed |
description | BACKGROUND: Although magnetic resonance imaging (MRI) is an important imaging modality for pre-operative staging and surgical planning of rectal cancer, to date there has been little investigation on the completeness and overall quality of MRI reports. This is important because optimal patient care depends on the quality of the MRI report and clear communication of these reports to treating physicians. Previous work has shown that the use of synoptic pathology reports improves the quality of pathology reports and communication between physicians. METHODS: The aims of this project are to develop a synoptic MRI report for rectal cancer and determine the enablers and barriers toward the implementation of a synoptic MRI report for rectal cancer in the clinical setting. A three-step Delphi process with an expert panel will extract the key criteria for the MRI report to guide pre-operative chemoradiation and surgical planning following a review of the literature, and a synoptic template will be developed. Furthermore, standardized qualitative research methods will be used to conduct interviews with radiologists to determine the enablers and barriers to the implementation and sustainability of the synoptic MRI report in the clinic setting. CONCLUSION: Synoptic MRI reports for rectal cancer are currently not used in North America and may improve the overall quality of MRI report and communication between physicians. This may, in turn, lead to improved patient care and outcomes for rectal cancer patients. |
format | Online Article Text |
id | pubmed-3224933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32249332011-11-29 Development of a synoptic MRI report for primary rectal cancer Spiegle, Gillian Leon-Carlyle, Marisa Schmocker, Selina Fruitman, Mark Milot, Laurent Gagliardi, Anna R Smith, Andy J McLeod, Robin S Kennedy, Erin D Implement Sci Study Protocol BACKGROUND: Although magnetic resonance imaging (MRI) is an important imaging modality for pre-operative staging and surgical planning of rectal cancer, to date there has been little investigation on the completeness and overall quality of MRI reports. This is important because optimal patient care depends on the quality of the MRI report and clear communication of these reports to treating physicians. Previous work has shown that the use of synoptic pathology reports improves the quality of pathology reports and communication between physicians. METHODS: The aims of this project are to develop a synoptic MRI report for rectal cancer and determine the enablers and barriers toward the implementation of a synoptic MRI report for rectal cancer in the clinical setting. A three-step Delphi process with an expert panel will extract the key criteria for the MRI report to guide pre-operative chemoradiation and surgical planning following a review of the literature, and a synoptic template will be developed. Furthermore, standardized qualitative research methods will be used to conduct interviews with radiologists to determine the enablers and barriers to the implementation and sustainability of the synoptic MRI report in the clinic setting. CONCLUSION: Synoptic MRI reports for rectal cancer are currently not used in North America and may improve the overall quality of MRI report and communication between physicians. This may, in turn, lead to improved patient care and outcomes for rectal cancer patients. BioMed Central 2009-12-02 /pmc/articles/PMC3224933/ /pubmed/19954526 http://dx.doi.org/10.1186/1748-5908-4-79 Text en Copyright ©2009 Spiegle et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Spiegle, Gillian Leon-Carlyle, Marisa Schmocker, Selina Fruitman, Mark Milot, Laurent Gagliardi, Anna R Smith, Andy J McLeod, Robin S Kennedy, Erin D Development of a synoptic MRI report for primary rectal cancer |
title | Development of a synoptic MRI report for primary rectal cancer |
title_full | Development of a synoptic MRI report for primary rectal cancer |
title_fullStr | Development of a synoptic MRI report for primary rectal cancer |
title_full_unstemmed | Development of a synoptic MRI report for primary rectal cancer |
title_short | Development of a synoptic MRI report for primary rectal cancer |
title_sort | development of a synoptic mri report for primary rectal cancer |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224933/ https://www.ncbi.nlm.nih.gov/pubmed/19954526 http://dx.doi.org/10.1186/1748-5908-4-79 |
work_keys_str_mv | AT spieglegillian developmentofasynopticmrireportforprimaryrectalcancer AT leoncarlylemarisa developmentofasynopticmrireportforprimaryrectalcancer AT schmockerselina developmentofasynopticmrireportforprimaryrectalcancer AT fruitmanmark developmentofasynopticmrireportforprimaryrectalcancer AT milotlaurent developmentofasynopticmrireportforprimaryrectalcancer AT gagliardiannar developmentofasynopticmrireportforprimaryrectalcancer AT smithandyj developmentofasynopticmrireportforprimaryrectalcancer AT mcleodrobins developmentofasynopticmrireportforprimaryrectalcancer AT kennedyerind developmentofasynopticmrireportforprimaryrectalcancer |